Wastewater Treatment and the Use of Nanoparticles, a Form of Circular Economy in the Pharmaceutical Industry

Miraute Coca Laura-Crina (), Casaneanu Dascalu Nicoleta Mihaela () and Pislaru Marius ()
Additional contact information
Miraute Coca Laura-Crina: “Gheorghe Asachi Technical University of Iasi-Romania, Iasi, Romania
Casaneanu Dascalu Nicoleta Mihaela: “Gheorghe Asachi Technical University of Iasi-Romania, Iasi, Romania
Pislaru Marius: “Gheorghe Asachi Technical University of Iasi-Romania, Iasi, Romania

Proceedings of the International Conference on Business Excellence, 2025, vol. 19, issue 1, 5467-5478

Abstract: People’s health is the most valuable “quality” they can acquire, and sometimes it depends or not on their actions. The pharmaceutical industry is often responsible for people’s health through the products it produces. However, the process of producing medicines can have significant effects on the environment. The good deeds of pharmaceutical companies also have consequences, and these ultimately end up being harmful to people as well. Based on the literature, this study aims to identify the possibility of implementing a circular economy at the level of the pharmaceutical industry, especially water consumption, which is perhaps the most exploited resource in pharmaceutical companies. The articles published between 2015 and 2024 from the Web of Science are used, which, with the VOSviewer software, are “transformed” into maps, thus representing the relationships between authors, the countries with the most publications, and the journals that published articles that address the research direction appropriate to the study. Also, methods for treating wastewater from the pharmaceutical industry have been identified, and it has been explained how drugs, more specifically antibiotics, can affect the environment and then humans and animals. In conclusion, the circular economy in the pharmaceutical industry is still a sufficiently unexplored topic to be applied with certainty, but it has potential, contributing to a reduction in environmental degradation caused by drug production. As research directions, the study can be expanded, the bibliographic analysis can be carried out in more detail, and even public data from companies operating in the pharmaceutical industry can be taken into account.

Keywords: circular economy; pharmaceutical industry; wastewater; VOSviewer; antibiotic. (search for similar items in EconPapers)
Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://doi.org/10.2478/picbe-2025-0417 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:vrs:poicbe:v:19:y:2025:i:1:p:5467-5478:n:1049

DOI: 10.2478/picbe-2025-0417

Access Statistics for this article

Proceedings of the International Conference on Business Excellence is currently edited by Alina Mihaela Dima

More articles in Proceedings of the International Conference on Business Excellence from Sciendo
Bibliographic data for series maintained by Peter Golla ().